What are the long-term outcomes of ixekizumab therapy in terms of durability of response and maintenance of skin clearance?

Featuring Tina Bhutani, MD, MAS | CEO, Synergy Dermatology Associate Clinical Professor of Dermatology University of California, SF San Francisco, CA | Published October 18, 2024